Preclinical and Clinical Role of Coenzyme Q10 Supplementation in Various Pathological States

Abstract

Coenzyme Q10 (CoQ10) is an efficient antioxidant produced endogenously in a living organism. It acts as an important cofactor in the electron transport system of mitochondria and reported as a safe supplement in humans and animals with minimal adverse effect. CoQ10 is found naturally, as a trans configuration, chemical nomenclature of which is 2,3- dimethoxy-5- methyl-6-decaprenyle -1,4-benzoquinone. It is found in the body in two forms. In quinone form (oxidized form), it serves as an electron transporter that transfers the electrons in the electron transport chain between various complexes, and in ubiquinol form (reduced form), it serves as potent antioxidants by scavenging free radicals or by tocopherol regeneration in the living organism. Its primary roles include synthesis of adenosine triphosphate (ATP), stabilizes lipid membrane, antioxidant activity, cell growth stimulation, and cell death inhibition. CoQ10 has shown a variety of pharmacological and clinical effects including neuroprotective, hepatoprotective, anti-atherosclerotic, anticonvulsant, antidepressant, anti-inflammatory, antinociceptive, cardiovascular, antimicrobial, immunomodulatory, and various effects on the central nervous system. Present review has set about to bring updated information regarding to clinical and preclinical activities of CoQ10, which may be helpful to researchers to explore a new bioactive molecules for various therapeutic application.

Key words

Antioxidants - Benzoquinone - Electron transporter - LD50 - Cofactor

Publication History

Received: 23 March 2022

Accepted: 25 April 2022

Article published online:
20 June 2022

• References

• 1 James AM, Smith RA, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys 2004; 423: 47-56
• 2 Bhagavan HN, RK Chopra. “Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics”. Free Radical Research 2006; 40: 445-453
• 3 Lass A, Sohal RS. Electron transport-linked ubiquinone-dependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes. Arch Biochem Biophys 1998; 352: 229-236
• 4 Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K. et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 2012; 52: 716-723
• 5 Merlo PM, Castagnoli A, Biondi A. et al. Ubiquinol and a coenzyme Q reducing system protect platelet mitochondrial function of transfusional buffy coats from oxidative stress. Free Radic Res 2002; 36: 429-436
• 6 Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Curr Cardiol Rev 2018; 14: 164-174
• 7 Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. Coenzyme Q10 in health and disease. Eur J Clin Nutr 1999; 53: 764-770
• 8 Craft NE, Tucker RT, Chitchumroonchokchai C, Failla M, Bhagavan HN. Assessment of coenzyme Q10 bioavailability using a coupled in vitro digestion/Caco-2 human intestinal cellmodel. FASEB J 2005; 19: A449
• 9 Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L. Mitochondrial dysfunction,oxidative stress and neurodegeneration. J. Alzheimers Dis 2006; 10: 59-73
• 10 Winkler-Stuck K, Wiedemann FR, Wallesch CW, Kunz WS. Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients”. J Neurol Sci 2004; 220: 41-48
• 11 Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M. Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 2006; 28: 125-141
• 12 Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A., Magis D. et al. Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology 2005; 64: 713-715
• 13 Kasparova S, Sumbalova Z, Bystricky P, Kucharska J, Liptaj T, Mlynarik V. et al. Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington’s disease. Neurochem Int 2006; 48: 93-99
• 14 Smith KM, Matson S, Matson WR, Cormier K. et al. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington’s disease mice. Biochim Biophys Acta 2006; 1762: 616-626
• 15 Stack EC, Smith KM, Ryu H, Cormier K. et al. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington’s disease mice. Biochim Biophys Acta 2006; 1762: 373-380
• 16 A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 2001; 57: 397–404
• 17 Tawfik MK. Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 2011; 22: 671-677
• 18 Sawsan AF. Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats”. Pharmacology Biochemistry and Behavior 2013; 104: 105-112
• 19 Lee BJ, Huang YC, Chen SJ, Lin PT. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary arterydisease. Nutrition 2012; 28: 767-772
• 20 Olivieri F, Lazzarini R, Babini L. et al. Anti-inflammatory effect of ubiquinol- 10 on young and senescent endothelial cells via miR-146a modulation. Free Radic Biol Med 2013; 63: 410-420
• 21 Schmelzer C, Lindner I, Rimbach G. et al. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 2008; 32: 179-183
• 22 Zhai J, Bo Y, Lu Y, Liu C, Zhang L. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta- Analysis. PLoS ONE 2017; 12: e0170172
• 23 Bauerovaa K, Kucharskab J, Mihalovaa D, Navarovaa J. et al. Effect of coenzyme Q10 supplementation in the rat model of adjuvant arthritis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 501-503
• 24 Kucharska J, Bauerova K, Sumbalova Z. et al. New methodology in efficiency testing of antirheumatics basedon determination of mitochondrial function and coenzyme Q9level in skeletal muscle of arthritic rats. Third Conference of theInternational Coenzyme Q10 Association, London, 2002. p. 136–137
• 25 Ayaz M, Tuncer S, Okudan N, Gokbel H. Coenzyme Q10 and alpha-lipoic acid supplementation in diabetic rats: Conduction velocity distributions. Methods Find Exp Clin Pharmacol 2008; 30: 367-374
• 26 Tie-Jun SS, Ming-Dong Z, Hugo Z. et al. Coenzyme Q10 prevents peripheral neuropathyand attenuates neuron loss in the db−/db− mouse, a type 2 diabetes model. PNAS 2013; 110: 690-695
• 27 Zhang YP, Eber A, Yuan Y. et al. Prophylactic and Antinociceptive Effects of Coenzyme Q10 on Diabetic Neuropathic Pain in a Mouse Model of Type 1 Diabetes. Anesthesiology 118 4 945-954
• 28 Pepe S, Marasco SF, Haas SJ. et al. Coenzyme Q10 in cardiovascular disease. Mitochondrion 2007; 7: S154-S167
• 29 Sharma A, Fonarow GC, Butler J. et al. Coenzyme Q10 and heart failure: A state-of-the-art review. Circ Heart Fail 2016; 9: e002639
• 30 De Frutos F, Gea A, Hernandez-Estefania R, Rabago G. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis. Interact. Cardiovasc Thorac Surg 2015; 20: 254-259
• 31 Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97: 268-275
• 32 Enster L, Dallner G. Biochemical, physicological and medical aspects of ubiquinone function. Biochemica Biophys Acta 1995; 1271: 195-204
• 33 Langsjoen P, Langsjoen P, Willis R, Folkers R. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med 1994; 15: 265-272
• 34 Kontush A. et al. Plasma ubiquinol is decreased in patients with hyperlipidemia. Atherosclerosis 1997; 129: 119-126
• 35 Yokoyama H. et al. Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. Surgery 1996; 120: 189-196
• 36 Lafuente R, González-Comadrán M, Solà I, López G. et al. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet 2013; 30: 1147-1156
• 37 Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011, Issue 1. Art. No.: CD007411. 10.1002/14651858. CD007411.pub2
• 38 Balercia G, Armeni T, Mantero F, Principato G, Regoli F. Total oxyradical scavenging capacity toward different reactive oxygen species in seminal plasma and sperm cells. Clin Chem Lab Med 2003; 41: 13-19
• 39 Alleva R, Scararmucci A, Mantero F, Bompadre S, Leoni L, Littarru GP. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Mol Aspects Med 1997; 18: S221-S228
• 40 Balercia G, Buldreghini E, Vignini A, Tiano L. et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Sterility 2009; 91: 1785-1792
• 41 Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79: 829-843
• 42 Fraga CG, Motchnik PA, Shigenaga MK. et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci 1991; 88: 11003-11006
• 43 Ross C, Morriss A, Khairy M, Khalaf Y, Braude P, Coomarasamy A. et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010; 20: 711-723
• 44 Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol 2009; 182: 237-248
• 45 Talevi R, Barbato V, Fiorentino I, Braun S, Longobardi S, Gualtieri R. “Protective effects of in vitro treatment with zinc, d-aspartate and coenzyme q10 on human sperm motility, lipid peroxidation and DNA fragmentation” Reproductive Biology and Endocrinology 2013, 16;11:81. 10.1186/1477-7827-11-81
• 46 Banihani SA. “Effect of Coenzyme Q10 Supplementation on Testosterone”. Biomolecules 2018; 8: 172
• 47 Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K. et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 2012; 52: 716-723
• 48 Eriksson J, Lindström J, Valle T. et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland: Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42: 793-801
• 49 Villalba JM, Parrado C, Santos-Gonzalez M. et al. Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 2010; 19: 535-554
• 50 Chew GT, Watts GF. Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the ‘recoupling hypothesis’. QJM 2004; 97: 537-548
• 51 Sena CM, Nunes E, Gomes A, Santos MS. et al. Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr Res 2008; 28: 113-121
• 52 Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes”. European Journal of Clinical Nutrition 2002; 56: 1137-1142
• 53 Amin MM, Asaad GF, Abdel Salam RM. et al. Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats. PLoS ONE 2014; 9: e89169
• 54 Carmona MC, Lefebvre P, Lefebvre B, Galinier A. et al. Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice. Int J Obes (Lond) 2009; 33: 204-211
• 55 Mansour SuzanM., Zaki HalaF., El-Denshary Ezz-El-DinS. Beneficial effects of co-enzyme Q10 and rosiglitazone in fructose-induced metabolic syndrome in rats. Bulletin of Faculty of Pharmacy, Cairo University 2013; 51: 13-21
• 56 Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB. et al. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009; 78: 1391-1400
• 57 Kunitomo M, Yamaguchi Y, Kagota S, Otsubo K. Beneficial Effect of Coenzyme Q10 on Increased Oxidative and Nitrative Stress and Inflammation and Individual Metabolic Components Developing in a Rat Model of Metabolic Syndrome. J Pharmacol Sci 2008; 107: 128-137
• 58 Fouad AA, Jresat I. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Envionmen toxico Pharmacol 2012; 33: 158-167
• 59 Amimoto T, Matsurahttp T, Koyama SY. et al. Acetaminophen-inducedhepatic injury in mice: the role of lipid peroxidation andeffects of pretreatment with coenzyme Q10 and α-tocopherol. Free Radic Biol Med 1995; 19: 169-176
• 60 Lamia SS, Emran T, Rikta JK, Chowdhury NI. et al. Coenzyme Q10 and Silymarin Reduce CCl4-Induced Oxidative Stress and Liver and Kidney Injury in Ovariectomized Rats-Implications for Protective Therapy in Chronic Liver and Kidney Diseases. Pathophysiology 2021; 28: 50-63
• 61 Fu Xin, Ji Rong, Jorgen D. Acute, subacute toxicity and genotoxic effect of CoQ10 in mice and rats. Regulatory Toxicology and Pharmacology 2009; 53: 1-5